Advertisement

Do Statins Increase the Risk for Herpes Zoster?

Summary and Comment |
February 12, 2014

Do Statins Increase the Risk for Herpes Zoster?

  1. Neil M. Ampel, MD

In a population-based retrospective study of individuals aged ≥66 in Ontario, Canada, statin use was associated with an 11.6% increase in HZ risk.

  1. Neil M. Ampel, MD

More than 60% of all cases of herpes zoster (HZ) occur in individuals aged ≥50. Although suppression of the cellular immune response has been linked to an increased incidence of HZ, the condition can develop in people with no identifiable risk factors. In 2008, 25% of Americans aged ≥45 were treated with statins. Used for their lipid-lowering properties, these agents have also been associated with reduced T-lymphocyte activation and proliferation. Until now, no studies have examined the possible effect of statins on HZ incidence.

To explore this possible effect, researchers conducted a population-based retrospective cohort study involving all Ontario residents aged ≥66 between April 1997 and March 2010. Medication exposure, hospitalization, and emergency department data were extracted from various databases. The 494,651 individuals who were prescribed a statin were matched 1:1 with statin-unexposed controls based on an algorithm-defined propensity score.

During the 13-year study period, HZ developed in 19,143 individuals, with the rate significantly higher among statin recipients than controls (13.3 vs 11.7/1000 person-years; hazard ratio 1.13; 95% confidence interval, 1.10–1.17). The attributable fraction of HZ cases among statin-exposed individuals was 11.6%.

Comment

Although these retrospective data do not assign causality, they do suggest that slightly more than one-tenth of all cases of HZ in older adults are attributable to statin use. As the authors note, such cases could total 20,000 annually in the U.S. alone, at an estimated cost to the healthcare system of $1 billion.

  • Disclosures for Neil M. Ampel, MD at time of publication Editorial boards Medical Mycology

Citation(s):

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement